Telix Pharmaceuticals Limited TLX
9.10 USD -0.41 -4.31%
At close
9.09 -0.01 -0.11%
Pre-market · Nov 2, 7:00 AM ET
- YTD
- +21.50%
- 1 year
- -15.19%
- Open
- 9.26
- Prev close
- 9.51
- Mkt cap
- 3.08B
- Vol
- 341.88K
- Avg vol
- 321.31K
- EPS
- 0.10
- P/E
- 91.00
- Div yield
- 0.00%
More statistics
- Low
- 8.98
- High
- 9.26
- Forward P/E
- -340.70
- Beta
- 0.56
- Short ratio
- 0.76
- Inst. own
- 1.02%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 19, 2027
- 50-d avg
- 11.12
- 200-d avg
- 9.90
- 1y target
- 20.56
MAX chart
Chart tools
Chart is warming up
The all-time price history for TLX has not been loaded yet. Try again in a moment.
Altman Z-Score
3.76 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
5 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 1
- Return on Equity 3
- Return on Assets 3
- Debt / Equity 1
- P/E 1
- P/B 1
P/E -362×
P/S 3.2×
P/B 6.1×
P/FCF -46.7×
EV/EBITDA 54.6×
EV/Sales 3.6×
FCF Yield -2.1%
Gross Margin 53.1%
Operating Margin 2.2%
Net Margin -0.9%
ROE -1.7%
ROIC 1.8%
ROA -0.6%
Revenue 0.8%
Operating Income -78.7%
EPS (diluted) -114.8%
Free Cash Flow -289.0%
Current Ratio 1.4×
Quick Ratio 1.3×
Debt / Equity 1.1×
Net Debt / EBITDA 6.2×
Interest Coverage 0.5×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31